Skip to main content
NCBI home page
Molecular Cancer logoLink to Molecular Cancer
. 2021 Apr 9;20:64. doi: 10.1186/s12943-021-01344-4

Correction to: LncRNA PTAR promotes EMT and invasionmetastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression

Haihai Liang 1,2,#, Tong Yu 1,2,#, Yue Han 3,#, Hua Jiang 1,2, Chengyu Wang 3, Tianyi You 3, Xiaoguang Zhao 1,2, Huitong Shan 1,2, Rui Yang 1,2, Lida Yang 1,2, Hongli Shan 1,2, Yunyan Gu 4,5,✉
PMCID: PMC8034128  PMID: 33836767

Correction to: Mol Cancer (2018) 17:119

https://doi.org/10.1186/s12943-018-0870-5

Following publication of the original article [1], the authors identified some minor errors in image-typesetting in Figs. 3, 4 and 7. Specifically, the following panels have been corrected:

Figure 3B

Figure 4A

Figure 4D

Figure 7D

The corrected figures are given below. The corrections do not have any effect on the final conclusions of the paper.

graphic file with name 12943_2021_1344_Fig1_HTML.jpg

Open in a new tab

graphic file with name 12943_2021_1344_Fig2_HTML.jpg

Open in a new tab

graphic file with name 12943_2021_1344_Fig3_HTML.jpg

Open in a new tab

graphic file with name 12943_2021_1344_Fig4_HTML.jpg

Footnotes

Haihai Liang, Tong Yu and Yue Han contributed equally to this work.

Reference

  • 1.Liang H, Yu T, Han Y, et al. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression. Mol Cancer. 2018;17:119. doi: 10.1186/s12943-018-0870-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES